NDC 51150-240-03
This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.
- Requested NDC
- 51150-240-03
- Product root
- 51150-240
- Identity scope
- Package
- Primary current NDC product row
- Not present
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 51150-240 | 51150-240-03 | D | Discontinued by firm | 2026-10-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lancome Paris Renergie HPN 300 Peptide Broad Spectrum SPF 25 Sunscreen | AVOBENZONE, OCTISALATE AND OCTOCRYLENE | SICOS ET CIE | 01c9c677-9da1-47d9-8b7e-b21f8450c5c3 | 2024-06-26 | Warnings | 51150-240-03 51150-240 51150024003 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.